Latest News and Press Releases

AscellaHealth Highlights Rare Disease Capabilities and End-to-End Specialty Pharmaceutical Solutions at World Orphan Drug Congress USA 2025

Rockville, MD, March 18, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the The global rare neurological disease treatment market was valued...

World Orphan Drug Alliance expands to Canada and full LATAM region, completing the first truly global commercialization offering.

BERWYN, Pa., Oct. 22, 2024 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, today released its latest...

AscellaHealth Announces Strategic Acquisition of CHAPPER healthcare: Expands Global Specialty Pharmaceutical Wholesale and Product Distribution Services

Oncopeptides expands on WODA partnership with addition of Africa and Eurasia to provide Pepaxti to Patients

World Orphan Drug Alliance Expands to Japan & South Korea and the African Subcontinent

Stakeholders debate at the North America Rare Disease Summit on the challenges regarding treatment approvals and the importance of a proactive registry

Visiongain has published a new report entitled Orphan Drugs Market Report 2023-2033: Forecasts by Therapeutic Area (Cancer, Neurological Diseases, Cardiovascular Diseases, Hematologic Disorders,...

Covina , Sept. 12, 2023 (GLOBE NEWSWIRE) -- Introduction: Orphan drugs are used to treat and diagnose an orphan disease which can be serious or even cause life-threating. Orphan drugs are not...